enGene Therapeutics (ENGN) Depreciation and Depletion (2023 - 2026)
enGene Therapeutics' Depreciation and Depletion came in at $178,000 for fiscal Q3 2026 (quarter ended Jul 31, 2026), up 36.9% from $130,000 a year earlier but down 1.1% from the prior quarter.
enGene Therapeutics (ENGN) Depreciation and Depletion (2023 - 2026) Analysis & Trends
Over the trailing twelve months to Jul 31, 2026, enGene Therapeutics reported Depreciation and Depletion of $718,000, up 70.5% year-over-year; for FY2025 (ended Oct 31, 2025), it came in at $509,000, up 57.6% from FY2024.
- Depreciation and Depletion carries a three-year compound annual growth rate of 28.8% (FY2022 to FY2025).
- Going back by fiscal year, Depreciation and Depletion was $323,000 in FY2024 (+84.6%), $175,000 in FY2023 (-26.5%) and $238,000 in FY2022.
- The five-year range for quarterly Depreciation and Depletion is $37,000 (fiscal Q2 2023) to $189,000 (fiscal Q1 2026).
- Year-over-year, Depreciation and Depletion has increased for 11 consecutive quarters, with growth averaging 61.2% over the last eight quarters.
- Across the past five years, year-over-year growth in Depreciation and Depletion ran from 27.5% in fiscal Q1 2025 to 110.8% in fiscal Q2 2024.
- Business Quant data shows ENGN's Depreciation and Depletion at $180,000 (Q2 2026), $189,000 (Q1 2026) and $171,000 (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 194.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 599.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 98.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | enGene Therapeutics | 130.01 Mn | 130.01 Mn | - | 178,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 178,000.00 |
| Apr 30, 2026 | 180,000.00 |
| Jan 31, 2026 | 189,000.00 |
| Oct 31, 2025 | 171,000.00 |
| Jul 31, 2025 | 130,000.00 |
| Apr 30, 2025 | 106,000.00 |
| Jan 31, 2025 | 102,000.00 |
| Oct 31, 2024 | 83,000.00 |
| Jul 31, 2024 | 82,000.00 |
| Apr 30, 2024 | 78,000.00 |
| Jan 31, 2024 | 80,000.00 |
| Oct 31, 2023 | 49,000.00 |
| Jul 31, 2023 | 43,000.00 |
| Apr 30, 2023 | 37,000.00 |
| Jan 31, 2023 | 46,000.00 |
enGene Therapeutics Depreciation and Depletion API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=ENGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-depletion", "ticker": "ENGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=ENGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();